Last year, my economists at the U.S. Congress Joint ... We wrote a detailed report that included the effects obesity can have on our national debt and how we can make America healthier and ...
Meanwhile, Eli Lilly’s stocks dipped ... of last year, the Danish pharmaceutical company experienced a 21% plunge in its share price following disappointing trial results for its new obesity ...
Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share price on Friday. View on euronews ...